BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10906622)

  • 1. Case 2. Recurrence of myocardial infarction.
    Tanser P; Archer S; Feldman R
    Can J Cardiol; 2000 Aug; 16 Suppl E():24E-26E. PubMed ID: 10906622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasmapheresis as treatment for severe hypertriglyceridemia].
    Manrique Franco K; Sánchez-Vilar Burdiel O; Aragón Valera C; Sánchez Fernández MS; Rovira Loscos A
    Endocrinol Nutr; 2011; 58(6):319-20. PubMed ID: 21459058
    [No Abstract]   [Full Text] [Related]  

  • 3. Case 1. Cardiovascular dysfunction syndrome.
    Leiter LA
    Can J Cardiol; 2000 Aug; 16 Suppl E():21E-23E. PubMed ID: 10906621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart attack: what is your risk?
    Am Fam Physician; 2010 Aug; 82(3):275. PubMed ID: 20672792
    [No Abstract]   [Full Text] [Related]  

  • 5. Basic approach to managing hyperglycemia for the nonendocrinologist.
    Deeg MA
    Am J Cardiol; 2005 Aug; 96(4A):37E-40E. PubMed ID: 16098842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Normalization of blood pressure and lipids in patients with diabetes].
    Clemens A; Gallwitz B
    Med Klin (Munich); 2003 Jul; 98(7):368-76. PubMed ID: 12937902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract]   [Full Text] [Related]  

  • 8. Meeting of the minds. Should pre-hypertension in type 2 diabetes be treated?
    Bihl G; Amod A; Ellis G; Moore R; Raal FJ; Gernholtz T; Schamroth C; Horak A
    Cardiovasc J Afr; 2010; 21(3 Suppl):S9-S13. PubMed ID: 20532426
    [No Abstract]   [Full Text] [Related]  

  • 9. [Integrated drug therapy of the metabolic syndrome].
    Julius U; Hanefeld M
    Internist (Berl); 1996 Jul; 37(7):722-30. PubMed ID: 8766266
    [No Abstract]   [Full Text] [Related]  

  • 10. Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease.
    Hengstenberg C; Holmer SR; Mayer B; Engel S; Schneider A; Löwel H; Riegger GA; Schunkert H
    Eur Heart J; 2001 Jun; 22(11):926-33. PubMed ID: 11428816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes.
    McGuire DK; Newby LK; Bhapkar MV; Moliterno DJ; Hochman JS; Klein WW; Weaver WD; Pfisterer M; Corbalán R; Dellborg M; Granger CB; Van De Werf F; Topol EJ; Califf RM;
    Am Heart J; 2004 Feb; 147(2):246-52. PubMed ID: 14760321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention by life style intervention and medication. To run away from type 2 diabetes].
    Wepner U
    MMW Fortschr Med; 2004 Apr; 146(14):16. PubMed ID: 15344745
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differentiated treatment of diabetics with an acute coronary syndrome].
    Hamm CW; Hamann A
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
    [No Abstract]   [Full Text] [Related]  

  • 14. ACCORD and Risk-Factor Control in Type 2 Diabetes.
    Nilsson PM
    N Engl J Med; 2010 Apr; 362(17):1628-30. PubMed ID: 20228405
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significant reduction of vascular risk factors within the framework of the population-based intervention project INVADE--a 2-year follow-up study].
    Sander K; Schulze Horn C; Briesenick C; Sander D
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1853-9. PubMed ID: 16915545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classical risk factors for myocardial infarction and total mortality in the community--13-year follow-up of the MONICA Augsburg cohort study].
    Heidrich J; Wellmann J; Hense HW; Siebert E; Liese AD; Löwel H; Keil U
    Z Kardiol; 2003 Jun; 92(6):445-54. PubMed ID: 12819993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of patients with essential hypertension. Clinical recommendations and economic data. Guidelines April 2000. Recommendations of the ANAES].
    Agence Nationale d'Accréditation et d'Evaluation en Santé
    J Mal Vasc; 2000 Dec; 25(5):366-376. PubMed ID: 11148400
    [No Abstract]   [Full Text] [Related]  

  • 18. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetics' life is about one third shorter. So you improve the prognosis of these high-risk patients].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Apr; 145(15):18, 20. PubMed ID: 15104261
    [No Abstract]   [Full Text] [Related]  

  • 20. [The kidneys and diabetes].
    Rüster C; Sämann A; Wolf G
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1848-52. PubMed ID: 18770486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.